 This study found that many mobile health applications, mHealth apps, for diabetes management have been approved by the Food and Drug Administration, FDA, however few have been evaluated for both efficacy and safety. Additionally, two mHealth apps were recalled due to programming errors which could lead to incorrect dosage recommendations. As such, it is important to ensure that mHealth apps are properly regulated and tested for both efficacy and safety before being released to the public. This article was authored by Avantika Patak, Susan Bain, and Inju Pasafaisi.